ea0081p675 | Pituitary and Neuroendocrinology | ECE2022
Bouca Bruno
, Roldao Marisa
, Bogalho Paula
, Cerqueira Luis
, Silva-Nunes Jose
Introduction: The endocrine complications of COVID-19 remain largely unknown. Cases of central diabetes insipidus (CDI) have been reported after COVID-19, with hypophysitis being the most likely cause. COVID-19 vaccines potential adverse effects may mimetize some of these complications. We present a case of a woman who developed CDI one week after the 2 nd dose of BNT162b2 mRNA COVID-19 vaccine.Case Report: Female patient, 37 years old, with rheumatoid a...